Despite recent progress, multiple myeloma remains incurable. Mezigdomide is a novel cereblon E3 ubiquitin ligase modulator with potent antiproliferative and tumoricidal activity in preclinical models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback